loader

World Tenders & Procurement Opportunities

Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Follitropin alfa (G03GA05) im Rahmen eines sogenannten Open-House-Modells.

World Biggest Tenders Source

This tender with title Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Follitropin alfa (G03GA05) im Rahmen eines sogenannten Open-House-Modells. -- Pharmaceutical products has been published on Bidding Source portal dated 19 May 2022 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Pharmaceutical products

General Information

Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Follitropin alfa (G03GA05) im Rahmen eines sogenannten Open-House-Modells.
Pharmaceutical products
Invitation for Bids
2022/S 095-261832
Germany
Germany-Eisenberg
19 May 2022
30 Apr 2024
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient interferon beta-1b (ATC code according to WHO: L03AB08) - 213676-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient fampridine (ATC code according to WHO: N07XX07) - 214649-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient octreotide (ATC code according to WHO: H01CB02) - 214791-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1b) - 217938-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1a) - 216318-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient sultamicillin (ATC code according to WHO: J01CR04) - 212806-2024 Germany Pharmaceutical products - discount agreements according to Section 130a Paragraph 8 SGB V for blood sugar test strips (open house procedure) - 210178-2024 Germany Pharmaceutical products – drug administration / blood products as of January 1, 2025 - 210490-2024 Germany Pharmaceutical products – Open framework agreement on drug discounts in accordance with Section 130a Paragraph 8 SGB V with the possibility of joining at any time, so-called approval model 2022-11 - 210740-2024 Germany Pharmaceutical products – pharmaceutical tender - 210889-2024 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans